Artiva Biotherapeutics, Inc. (ARTV)
(Real Time Quote from BATS)
$12.54 USD
-0.84 (-6.28%)
Updated Nov 12, 2024 02:36 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/5/24 |
---|---|
Current Quarter | -0.68 |
EPS Last Quarter | -19.10 |
Last EPS Surprise | -1,685.05% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.60 |
Next Year | -2.70 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30M | 0.30M | 0.70M | NA |
# of Estimates | 1 | 1 | 2 | NA |
High Estimate | 0.30M | 0.30M | 1.15M | NA |
Low Estimate | 0.30M | 0.30M | 0.25M | NA |
Year ago Sales | NA | NA | NA | 0.70M |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.68 | -0.63 | -4.60 | -2.70 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.63 | -0.58 | -4.55 | -2.63 |
High Estimate | -0.60 | -0.58 | -3.31 | -2.28 |
Low Estimate | -0.80 | -0.67 | -5.95 | -3.20 |
Year ago EPS | NA | NA | NA | -4.60 |
Year over Year Growth Est. | NA | NA | NA | 41.30% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.68 | -0.63 | -4.60 | -2.70 |
7 Days Ago | -0.68 | -0.63 | -4.60 | -2.70 |
30 Days Ago | -0.68 | -0.63 | -4.60 | -2.70 |
60 Days Ago | -0.68 | -0.63 | -4.60 | -2.70 |
90 Days Ago | -0.80 | -0.63 | -3.60 | -2.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.68 | -0.63 | -4.60 | -2.70 |
Zacks Consensus Estimate | -0.68 | -0.63 | -4.60 | -2.70 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -19.10 | NA | NA | NA | NA |
Estimate | -1.07 | NA | NA | NA | NA |
Difference | -18.03 | NA | NA | NA | -18.03 |
Surprise | -1,685.05% | NA | NA | NA | -1,685.05% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more